HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Cancer immunomodulation by carbohydrate ligands for the lymphocyte receptor NKR-P1.

Abstract
Natural killer (NK) and T cells express a superfamily of proteins with structural features of C-type lectins. Recombinantly prepared soluble form of rat NKR-P1 (CD161) recognized carbohydrate GalNac and GlcNac moieties. Ganglioside GM2 and heparin related-IS oligosaccharides representing the high affinity ligands for this receptor, increased the sensitivity of targets for killing by the rat effectors isolated from blood and spleen in vitro. Based on these results, we investigated in vivo the possible therapeutic effect of GM2 and IS carried by liposomes during induced rat colorectal carcinogenesis. The reduction of cancer incidence versus the controls (50% vs 88.88%), approached the 5-fluorouracil treatment (41.66%).
AuthorsM Pospisil, L Vannucci, O Horvath, A Fiserova, K Krausova, K Bezouska, F Mosca
JournalInternational journal of oncology (Int J Oncol) Vol. 16 Issue 2 Pg. 267-76 (Feb 2000) ISSN: 1019-6439 [Print] Greece
PMID10639569 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antigens, Surface
  • Antimetabolites, Antineoplastic
  • Carcinogens
  • Drug Carriers
  • Lectins, C-Type
  • Liposomes
  • NK Cell Lectin-Like Receptor Subfamily B
  • Oligosaccharides
  • G(M2) Ganglioside
  • Azoxymethane
  • Fluorouracil
Topics
  • Animals
  • Antigens, Surface (drug effects)
  • Antimetabolites, Antineoplastic (therapeutic use)
  • Azoxymethane
  • Carcinogens
  • Colorectal Neoplasms (chemically induced, drug therapy)
  • Drug Carriers
  • Drug Screening Assays, Antitumor
  • Escherichia coli
  • Fluorouracil (therapeutic use)
  • G(M2) Ganglioside (therapeutic use)
  • Lectins, C-Type
  • Liposomes
  • Male
  • NK Cell Lectin-Like Receptor Subfamily B
  • Oligosaccharides (therapeutic use)
  • Rats
  • Rats, Sprague-Dawley

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: